SCR-LIP-000333 · Claim · machine-readable JSON →
This narrative review describes lipedema as progressing through four stages culminating in stage 4 lipolymphedema, with chronic pain, swelling, and reported lymphovascular dysfunction (e.g., decreased PROX-1, increased VEGFR-3/VEGF-C, endothelial permeability), while noting it remains unclear whether lymphatic dysfunction is cause or consequence.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema: Insights into Morphology, Pathophysiology, and Challenges — Poojari et al. (2022) ✓ verified — consistent · review · 2022 · reading confidence: high
“Quatro estágios progressivos (E1 nódulos perolados; E2 depressões + fascia perilobular contraída; E3 lobos deformantes + perda de elasticidade; E4 lipolinfedema)”
The review explicitly outlines a progressive staging system ending in lipolymphedema (stage 4) and associates lipedema with chronic pain and functional/discomfort symptoms, supporting the affirmative direction; however, it is a narrative sy
Context (PECO)
Answers these questions
- Does lipedema progress to lymphedema and cause functional disability? consistent
- Does lipedema progress to lymphedema (lipo-lymphedema)? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000017